Search This Blog

Monday, March 2, 2020

Rhythm Pharmaceuticals EPS beats by $0.10

Rhythm Pharmaceuticals (NASDAQ:RYTM): Q4 GAAP EPS of -$0.78 beats by $0.10.
Cash, cash equivalents and short-term investments of $292.5M.
Press Release
https://seekingalpha.com/news/3547375-rhythm-pharmaceuticals-eps-beats-0_10
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)